OakChart

Omnicell Inc

OMCLHealthcare·Health Information Services·USA·Small·NASD·Nov 11 • 10:19 AM ET

35.45-0.45 (-1.25%)
2026-11-11 16:19 CET
Market cap
1,651.22 USD m
Revenue, TTM
1,243.92 USD m
Net income, TTM
44.66 USD m
Free cash flow, TTM
143.34 USD m
EPS diluted, TTM
0.96
P/E
36.76
Compare

Price

OMCL against its 20, 50 and 200-day averages
2050200beat
35.0040.0045.001.3M2.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26OMCLclose 35.4520-day 36.6750-day 35.05200-day 38.5035.45

31.6% under 51.84 on 13 Jan 2026. Last 15 sessions, 14.9% high to low

Profile

OMCL
52-week range, 18% of the way up
31.7551.84

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

IndexRUT
Employees3580
IPOAug 07, 2001
Beta0.89
ATR, 14d1.67
Rel volume0.29
Short float8.49%
Insider own3.40%
Inst own108.17%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.63B
Enterprise Value1.49B
Income44.66M
Sales1.24B
Book/sh28.64
Cash/sh7.34
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3580
IPOAug 07, 2001

Ratios

P/E36.76
Forward P/E17.65
PEG1.51
P/S1.31
P/B1.24
P/C4.83
P/FCF11.38
EV/EBITDA9.22
EV/Sales1.20
Quick Ratio1.41
Current Ratio1.62
Debt/Eq0.15
LT Debt/Eq0.14
Option/ShortYes / Yes

Earnings

EPS (ttm)0.96
EPS next Y2.01
EPS next Q0.42
EPS this Y53.32%
EPS next Y-19.12%
EPS next 5Y11.70%
EPS past 3/5Y-28.87% -43.00%
Sales past 3/5Y-2.94% 5.84%
EPS Y/Y TTM126.76%
Sales Y/Y TTM5.62%
EPS Q/Q99.75%
Sales Q/Q-0.89%
EarningsOct 29 BMO
EPS/Sales Surpr.38.92% 1.12%

Ownership

Insider Own3.40%
Insider Trans-1.34%
Inst Own108.17%
Inst Trans3.63%
ROA2.23%
ROE3.52%
ROIC2.96%
Gross Margin45.14%
Oper. Margin5.28%
Profit Margin3.59%
SMA20-3.33%
SMA501.14%
SMA200-7.91%
Trades-

Technical

Shs Outstand45.99M
Shs Float44.43M
Short Float8.49%
Short Ratio6.35
Short Interest3.77M
52W High51.84 -31.62%
52W Low31.75 11.65%
Volatility5.86% 4.53%
ATR (14)1.67
RSI (14)46.05
Beta0.89
Rel Volume0.29
Avg Volume594.28K
Volume29,331

Performance

Perf Week-10.05%
Perf Month-2.74%
Perf Quarter-5.82%
Perf Half Y-17.88%
Perf YTD-21.74%
Perf Year-4.47%
Perf 3Y15.25%
Perf 5Y-80.14%
Perf 10Y10.95%
Recom1.25
Target Price57.43
Prev Close35.90
Price35.45
Change %-1.25%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Feb 04, 2026UpgradeBBofA SecuritiesNeutral → Buy$70+97.5%
Jan 08, 2026UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$60+69.3%
May 14, 2025UpgradeWWells FargoEqual Weight → Overweight$35-1.3%
Oct 31, 2024DowngradeBBofA SecuritiesBuy → Neutral$44 → $57+60.8%
Aug 02, 2024UpgradeBBarclaysUnderweight → Equal Weight$26 → $39+10.0%
Jan 03, 2024InitiatedBBarclaysUnderweight$33-6.9%
Nov 03, 2023UpgradeWWells FargoUnderweight → Equal Weight$39 → $28-21.0%
Nov 03, 2023UpgradePPiper SandlerNeutral → Overweight$70 → $39+10.0%
Nov 03, 2023DowngradeBBTIG ResearchBuy → Neutral
Oct 11, 2023DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight

Peers

Mkt cap
TickerCompanyMkt cap
BDXBecton Dickinson & Co57.88B
HSTMHealthstream Inc870.59M
BAXBaxter International Inc13.59B
ICUIICU Medical Inc4.50B
WAYWaystar Holding Corp5.53B
SPOKSpok Holdings Inc246.97M
PHRPhreesia Inc788.30M
GRDNGuardian Pharmacy Services Inc3.13B
MCKMckesson Corp124.09B
CAHCardinal Health Inc63.96B

Insider trading

latest 14 of 23
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Njoku NnamdiPresident & COOAug 17 '26Sale36.853,083113,609161,224Aug 18 04:05 PM
Njoku NnamdiOfficerAug 17 '26Proposed Sale36.853,083113,609Aug 17 10:08 AM
LIPPS RANDALL ACHAIRMAN, CEOJul 15 '26Sale47.0010,000470,000345,861Jul 17 04:05 PM
Randall LippsOfficerJul 15 '26Proposed Sale47.0010,000470,000Jul 15 04:10 PM
Njoku NnamdiEVP, Chief Operating OfficerMay 18 '26Sale43.223,090133,550154,785May 19 05:05 PM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERMay 18 '26Sale43.225,025217,180112,783May 19 05:05 PM
Manley Corey JOfficerMay 18 '26Proposed Sale43.225,025217,180May 18 10:35 AM
Njoku NnamdiOfficerMay 18 '26Proposed Sale43.223,090133,550May 18 10:26 AM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERMar 16 '26Sale34.697,405256,87996,717Mar 17 04:05 PM
Manley Corey JOfficerMar 16 '26Proposed Sale34.697,405256,879Mar 16 11:36 AM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERFeb 17 '26Sale36.594,243155,25185,496Feb 18 04:05 PM
Manley Corey JOfficerFeb 17 '26Proposed Sale36.594,243155,251Feb 17 10:56 AM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERJan 08 '26Sale49.906,106304,68991,674Jan 12 04:05 PM
Manley Corey JOfficerJan 08 '26Proposed Sale49.906,106304,689Jan 08 10:30 AM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B

News

latest 14 of 206
  • Omnicell's Margin-Driven Beat And Third Profit Raise Mask A Top Line Still Waiting On Titan XT (Earnings Whispers)
  • Omnicell: Q3 Earnings Snapshot (Associated Press)
  • Omnicell Announces Third Quarter 2026 Financial Results (Business Wire)
  • Omnicell's Bookings Range Faces Its First Test As Earnings Reset After Tariff Windfall (Earnings Whispers)
  • Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 (Business Wire)
  • Loading…
  • TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations (PR Newswire)
  • Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference (Business Wire) +6.29%
  • Omnicell Inc (OMCL) (Q2 2026) Earnings Call Highlights: Strong Profitability and Strategic Wins ... (GuruFocus.com) -10.36%
  • Omnicell: Q2 Earnings Snapshot (Associated Press)
  • Omnicell Announces Second Quarter 2026 Financial Results (Business Wire)
  • Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 (Business Wire)
  • Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 (Business Wire)
  • Omnicell to Present at the BofA Securities 2026 Healthcare Conference (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-290.5800.4180.240307.85304.448
2026Q22026-07-300.9400.4680.525312.21310.218
2026Q12026-04-280.5500.3310.247309.88304.028
2025Q42026-02-050.4000.496-0.045313.98313.358
2025Q32025-10-300.5100.3630.119310.63295.68
2025Q22025-07-310.4500.2700.120290.56275.267
2025Q12025-05-060.2600.205-0.151269.67259.948
2024Q42025-02-060.6000.5840.338306.88299.999
2024Q32024-10-300.5600.4190.186282.42280.449
2024Q22024-08-010.5100.1440.081276.79254.419
2024Q12024-05-020.030-0.093-0.343246.15236.779
2023Q42024-02-080.3300.154-0.316258.85255.529
2023Q32023-11-020.6200.4660.122298.66295.477
2023Q22023-08-010.5700.2820.076298.97284.529
2023Q12023-05-020.3900.068-0.334290.63277.659
2022Q42023-02-280.3300.082-0.636297.71287.169

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.3301.3070.788716.17723.63
2018FY2.0902.0410.930787.31790.97
2019FY2.8102.8211.428897.03892.42
2020FY2.5402.4430.736892.21888.72
2021FY3.8103.8341.6241,1331,132
2022FY3.0002.7400.1231,2971,286
2023FY1.9101.731-0.4511,1471,144
2024FY1.7101.6900.2711,1121,105
2025FY1.6201.7160.0401,1851,184
2026FY-2.484--1,229
2027FY-2.009--1,240
2028FY-2.258--1,285

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-30808298.56296.4300.94
2026Q4S2026-10-29807300.37296.4313.41
2026Q4S2026-10-14800310.48304.39317
2026Q4S2026-10-13801310.48304.39317
2026Q4S2026-10-11805310.48304.39317
2026Q4S2026-07-31806310.48304.39317
2026Q4S2026-07-30805310.93304.39317
2026Q4S2026-07-28801314.51309.4319.81
2026Q4S2026-07-12800315.18309.4319.81
2026Q4S2026-04-28804315.18309.4319.81
2026Q4S2026-04-21800318.89309328.6
2026Q4S2026-02-05806318.89309328.6
2026Q4S2026-01-17710329.54318.8341.12
2026Q4S2026-01-13720329.54318.8341.12

Estimate history

EPS, annual0.7880.931.4280.7361.6240.123-0.4510.2710.0440.9644
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1860.338-0.1510.120.119-0.0450.2470.5250.238
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual712.714787.309897.027892.2081132.0181295.9471147.1121112.2381184.8451243.92
Period201720182019202020212022202320242025TTM
Sales, quarterly282.42306.879269.668290.562310.631313.984309.88312.208307.851
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual38.43240.33542.13242.78344.17944.74745.53946.38245.02745.994
Period201720182019202020212022202320242025MRQ
Shares, quarterly46.31346.38246.84446.41944.87645.02745.47745.61345.994
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,243.921,184.851,112.241,147.111,295.951,132.02892.21897.03787.31
Cost of Goods Sold Incl. D&A682.47676.80636.73647.18698.94576.98476.35460.12414.98
Gross Profit561.45508.04475.51499.93597.00555.04415.86436.91372.33
Selling, General and Administrative Excl. Other495.80496.38470.02519.26576.52452.81370.37358.56324.04
Research and Development86.7287.7389.9993.29101.3575.6166.4468.6464.84
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income65.6511.665.49-19.3320.48102.2345.4978.3548.29
Interest Expense5.133.914.534.534.5022.392.105.807.50
Unusual Expense1.006.50-2.3615.5422.8012.729.960.003.90
Net Income Before Taxes67.2411.3225.59-20.11-2.4566.0129.3573.9335.62
Income Taxes22.589.2713.060.26-8.10-11.84-2.8512.60-2.11
Consolidated Net Income44.662.0512.53-20.375.6577.8532.1961.3437.73
Net Income From Continuing Operations44.662.0512.53-20.375.6577.8532.1961.3437.73
Net Income44.662.0512.53-20.375.6577.8532.1961.3437.73
EPS (Recurring)0.980.140.24-0.210.471.810.901.431.00
EPS (Basic, Before Extraordinaries)0.980.040.27-0.450.131.790.761.480.96
EPS (Diluted)0.960.040.27-0.450.121.620.741.430.93
EBITDA161.9798.3095.2576.23119.65187.16117.08142.4799.64
Non-Operating Income (Expense)7.7210.0722.2619.294.37-1.11-4.081.39-1.28
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense35.6335.1644.7243.6953.9238.8132.6324.8622.39
Price To Earnings Ratio37.2337.23--49.72111.03163.9257.4066.54
Price To Sales Ratio1.271.771.851.481.797.645.883.913.15
Gross Margin45.1442.8842.7543.5846.0749.0346.6148.7147.29
Operating Margin5.280.980.49-1.691.589.035.108.736.13
Net Margin3.590.171.13-1.780.446.883.616.844.79
Shares Outstanding45.9945.0346.3845.5444.7544.1842.7842.1340.34
Market Capitalization1,651.221,651.222,062.021,711.012,251.247,929.025,077.713,427.172,426.70

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue307.85312.21309.88313.98310.63290.56269.67306.88
Cost of Goods Sold Incl. D&A170.03159.27169.52183.66176.13162.88158.73163.95
Gross Profit137.83152.94140.36130.32134.50127.68110.94142.93
Selling, General and Administrative Excl. Other122.89120.49123.51128.91126.26119.56122.56129.16
Research and Development22.3520.3021.5222.5524.0221.5720.5325.92
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income14.9332.4516.851.418.248.12-11.6213.77
Interest Expense0.740.740.732.920.290.350.351.11
Unusual Expense0.000.000.001.000.000.000.001.37
Net Income Before Taxes15.8033.8316.910.709.7010.45-9.5323.60
Income Taxes4.769.545.552.734.244.81-2.517.76
Consolidated Net Income11.0424.2911.36-2.035.465.64-7.0215.84
Net Income From Continuing Operations11.0424.2911.36-2.035.465.64-7.0215.84
Net Income11.0424.2911.36-2.035.465.64-7.0215.84
EPS (Recurring)0.240.520.25-0.030.120.12-0.150.36
EPS (Basic, Before Extraordinaries)0.240.530.25-0.050.120.12-0.150.34
EPS (Diluted)0.240.520.25-0.050.120.12-0.150.34
EBITDA41.8559.5637.3523.2029.6129.7710.2235.98
Non-Operating Income (Expense)1.612.120.793.211.752.682.4412.32
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.029.647.509.468.868.328.527.14
Price To Earnings Ratio37.2394.11772.69106.2461.7364.70133.28-
Price To Sales Ratio1.271.541.251.721.191.201.431.88
Gross Margin44.7748.9845.3041.5143.3043.9441.1446.57
Operating Margin4.8510.395.440.452.652.79-4.314.49
Net Margin3.597.783.67-0.651.761.94-2.605.16
Shares Outstanding45.9945.6145.4845.0344.8846.4246.8446.38
Market Capitalization1,651.221,888.281,516.652,032.911,398.701,377.201,634.712,062.02

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments251.03398.61500.98352.83355.62485.93127.2167.1932.42
Short Term Receivables231.51268.87263.89310.95251.56200.36228.13204.97198.81
Inventories100.9188.66110.10147.55119.9296.30108.01100.8796.14
Other Current Assets85.8159.3552.6070.4753.6046.8319.8924.1024.90
Total Current Assets669.25815.49927.57881.81780.70829.41483.24397.13352.27
Net Property, Plant & Equipment144.48138.30133.59132.01119.69114.19110.3851.5042.59
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable64.2660.6254.8047.6736.4839.3632.0133.5624.91
Intangible Assets962.25981.431,013.641,057.941,113.51761.55546.48536.39544.46
Deferred Tax Assets58.3457.4732.9022.3315.8815.0214.1415.209.45
Other Assets76.1467.6564.3769.0076.2364.9854.5747.4642.67
Total Assets1,974.722,120.962,226.882,210.762,142.501,824.501,240.811,081.241,016.36
Short Term Debt Incl. Current Port. of LT Debt11.96185.0310.5210.76501.1012.2010.060.0015.21
Accounts Payable43.9951.7845.0363.3971.5140.3146.3838.0448.29
Income Tax Payable4.0211.442.199.643.773.523.745.889.18
Other Current Liabilities416.65347.43310.06344.65299.77220.40176.81160.66132.53
Total Current Liabilities476.61595.68367.79428.45876.16276.42237.00204.58205.21
Long Term Debt192.39197.52603.57605.9839.91516.10100.67135.42194.92
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.681.111.622.1051.7039.6339.0941.4841.45
Other Liabilities73.2283.3464.9444.1028.0324.8518.8020.1420.45
Total Liabilities742.91877.651,037.921,080.62995.81857.00395.56401.62462.02
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,231.811,243.311,188.951,130.141,146.69967.50845.25679.62554.34
Total Shareholders Equity1,231.811,243.311,188.951,130.141,146.69967.50845.25679.62554.34
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,231.811,243.311,188.951,130.141,146.69967.50845.25679.62554.34
Total Liabilities & Stockholders Equity1,974.722,120.962,226.882,210.762,142.501,824.501,240.811,081.241,016.36
Book Value Per Share27.3626.8126.1125.2625.9622.6120.0616.8514.42
Tangible Book Value Per Share5.995.653.851.610.754.817.093.550.26
Full-Time Employees3,5803,6703,6504,2303,8002,8602,7002,4802,350
Price to Book Ratio1.251.671.441.986.955.314.073.633.89
Return on Assets0.100.58-0.920.263.922.105.283.663.13
Return on Equity0.171.03-1.760.507.363.558.056.306.19
Return on Invested Capital0.140.87-1.140.336.562.176.484.634.07
Quick Ratio1.191.222.221.710.752.651.581.451.25
Current Ratio1.401.372.522.060.893.002.041.941.72

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income44.662.0512.53-20.375.6577.8532.1961.3437.73
Depreciation83.3686.6389.7595.5699.1784.9371.5964.1251.35
Other Funds (Non Cash)48.3348.2441.9673.2883.7575.6451.3334.3831.31
Funds from Operations187.23135.63129.39137.42151.25235.15148.57158.50114.68
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-1.01-8.3358.3343.67-73.47-3.3437.30-15.81-10.72
Cash from Operating Activities186.22127.30187.72181.0977.78231.81185.87142.69103.97
Capital Expenditures-55.92-60.36-52.79-55.02-60.74-58.34-54.87-61.66-54.37
Net Assets From Acquisitions0.000.000.000.00-3.39-354.16-225.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.005.460.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00-
Cash from Investing Activities-55.92-60.36-52.79-55.02-58.67-412.50-279.87-61.66-54.37
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock15.72-60.7338.5823.22-12.0367.3552.5278.5130.61
Repurchase of Common Pref Stock0.00-77.600.000.00-52.210.00-53.030.000.00
Sale of Common Pref Stock15.7216.8738.5823.2240.1867.35105.5678.5130.61
Proceedsfrom Stock Options0.000.0025.170.000.000.0051.2937.810.00
Issuance or Reduction of Debt, Net0.00-175.00-265.73-2.970.000.00408.49-90.00-77.00
Change in Long Term Debt0.00-175.00-265.73-2.970.000.00408.49-90.00-77.00
Issuance of Long Term Debt0.000.00166.270.000.000.00709.660.000.00
Reduction of Long Term Debt0.00-175.00-432.01-2.970.000.00-301.18-90.00-77.00
Net Financing Active Other Cash Flow-32.5417.41-8.423.17-8.93-19.98-4.75-9.6732.79
Other Financing Activities Uses-41.65-7.68-8.42-7.37-13.51-19.98-8.74-9.67-6.78
Cash from Financing Activities-16.82-218.32-235.5823.42-20.9547.36456.27-21.16-13.60
Exchange Rate Effect-1.283.80-1.72-1.35-0.94-0.970.440.15-1.23
Net Change in Cash112.20-147.58-102.36148.14-2.79-134.30362.7160.0234.77
Free Cash Flow143.3484.45151.26139.6230.25202.84163.03126.7980.27
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow11.0424.8713.6112.1976.5042.6532.2027.6830.94
Deferred Taxes & Investment Tax Credit--1.29-14.86-11.05-37.32-3.27-6.55-1.34-5.71

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments337.65322.75290.96251.03225.46431.50
Short Term Receivables252.34241.90264.21231.51259.11245.31
Inventories98.2896.7299.20100.91107.43105.78
Other Current Assets77.2760.1452.5585.8151.1751.27
Total Current Assets765.54721.51706.94669.25643.16833.86
Net Property, Plant & Equipment147.40143.50144.45144.48145.70147.21
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets942.55949.95955.75962.25965.64972.07
Deferred Tax Assets44.8947.3854.0658.3456.3959.80
Other Assets86.7977.8481.9076.1480.0372.85
Total Assets2,056.841,998.862,004.111,974.721,948.602,145.50
Short Term Debt Incl. Current Port. of LT Debt11.0811.4811.6211.9611.89186.66
Accounts Payable60.8249.7858.3443.9962.4962.41
Income Tax Payable3.622.905.654.023.983.33
Other Current Liabilities398.18383.28407.43416.65378.23341.99
Total Current Liabilities473.70447.44483.05476.61456.59594.39
Long Term Debt189.67188.51190.56192.39194.89197.75
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.640.640.640.681.261.31
Other Liabilities75.5870.6673.2373.2274.9588.42
Total Liabilities739.58707.25747.48742.91727.70881.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,317.261,291.611,256.631,231.811,220.901,263.62
Total Shareholders Equity1,317.261,291.611,256.631,231.811,220.901,263.62
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,317.261,291.611,256.631,231.811,220.901,263.62
Total Liabilities & Stockholders Equity2,056.841,998.862,004.111,974.721,948.602,145.50
Book Value Per Share28.6428.3227.6327.3627.2127.22
Tangible Book Value Per Share8.157.496.625.995.696.28
Full-Time Employees---3,580-3,650
Price to Book Ratio1.251.501.221.671.121.10
Return on Assets2.231.890.980.100.941.04
Return on Equity3.523.061.630.171.621.87
Return on Invested Capital0.731.640.78-0.140.390.39
Quick Ratio1.411.401.261.191.171.22
Current Ratio1.621.611.461.401.411.40

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income11.0424.2911.36-2.035.465.64
Depreciation20.3320.7520.5021.7821.3621.65
Other Funds (Non Cash)12.2412.8210.1213.1512.0211.44
Funds from Operations46.1064.5546.2030.3842.2140.43
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-13.053.778.30-0.03-13.942.33
Cash from Operating Activities33.0568.3154.5030.3528.2742.76
Capital Expenditures-13.11-12.53-15.87-14.42-14.28-15.92
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-13.11-12.53-15.87-14.42-14.28-15.92
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock6.160.107.761.71-55.05-15.65
Repurchase of Common Pref Stock0.000.000.000.00-61.95-15.65
Sale of Common Pref Stock6.160.107.761.716.900.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.00-175.000.00
Change in Long Term Debt0.000.000.000.00-175.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.00-175.000.00
Net Financing Active Other Cash Flow-11.08-23.47-5.377.3910.074.18
Other Financing Activities Uses-11.08-23.47-5.37-1.72-5.924.18
Cash from Financing Activities-4.93-23.382.399.10-219.98-11.47
Exchange Rate Effect-0.12-0.62-1.090.55-0.051.74
Net Change in Cash14.9031.7939.9325.58-206.0417.10
Free Cash Flow21.6959.3742.0620.2118.5130.97
Price to Free Cash Flow11.0413.7213.7224.1212.5412.93

Revenue breakdown

Connected Devices, Software Licenses, And Other2024: 539.17M 2025: 565.48M
Consumables2024: 91.34M 2025: 100.22M
SaaS and Expert Services2024: 243.52M 2025: 259.09M
Technical Services2024: 238.21M 2025: 260.06M
Non-US2024: 99.87M 2025: 119.77M
United States2024: 1.01B 2025: 1.07B
Total Electronic Computers revenue2024: 1.11B 2025: 1.18B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.49%3.8M44.4M605.02K
2026-10-157.41%3.3M44.1M657.31K
2026-09-308.26%3.6M44.1M686.34K
2026-09-157.47%3.3M44.1M745.11K
2026-08-317.48%3.3M44.1M755.18K
2026-08-147.65%3.4M44.1M716.52K
2026-07-317.88%3.5M44.0M691.63K
2026-07-158.17%3.6M43.9M661.55K
2026-06-307.24%3.2M43.9M623.01K
2026-06-157.19%3.2M43.9M567.25K
2026-05-296.77%3.0M43.9M564.95K
2026-05-156.10%2.7M44.0M595.98K
2026-04-306.07%2.7M44.5M707.09K
2026-04-155.71%2.5M44.1M633.52K
2026-03-315.67%2.5M44.1M665.86K
2026-03-136.32%2.8M44.1M676.56K
2026-02-276.06%2.7M44.1M662.77K
2026-02-135.81%2.5M43.6M627.01K
2026-01-305.19%2.3M43.5M505.68K
2026-01-156.16%2.7M43.5M516.92K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.5016.9020.800.005.7940.000.000.913-0.2210.009
call20.0014.1018.300.004.9640.000.000.896-0.2140.010
call22.5011.7015.800.004.2400.000.000.877-0.2040.011
call25.009.1012.700.003.1780.000.000.853-0.1930.013
call30.004.008.306.652.4384.000.000.780-0.1590.017
call35.000.053.304.001.34143.000.000.577-0.1230.022
call40.000.002.850.291.99238.001.000.417-0.2420.022
call45.000.004.700.172.58632.000.000.357-0.2990.021
call50.000.000.950.361.99735.000.000.179-0.1620.015
call55.000.004.902.002.28016.000.000.162-0.1750.014
call60.000.002.850.052.63412.000.000.148-0.1880.013
call65.000.002.851.702.89515.000.000.138-0.1980.012
call70.000.004.900.003.1300.000.000.131-0.2060.012
put17.500.003.400.204.4851110.00-0.087-0.2190.009
put20.000.002.851.103.8221.000.00-0.103-0.2120.010
put22.500.002.850.003.2180.000.00-0.123-0.2020.011
put25.000.004.902.802.6821.000.00-0.147-0.1900.013
put30.000.002.650.151.7168.000.00-0.220-0.1560.017
put35.000.001.400.800.8561480.00-0.388-0.1150.022
put40.001.955.904.001.3787.000.00-0.583-0.2370.022
put45.006.8010.907.101.9317.000.00-0.643-0.2940.021
put50.0011.8015.8014.212.3120.000.00-0.821-0.1570.015
put55.0017.5021.100.002.8580.000.00-0.839-0.1710.014
put60.0021.8026.000.002.9930.000.00-0.852-0.1820.013
put65.0027.4030.800.003.2720.000.00-0.862-0.1910.012
put70.0031.7036.100.003.7230.000.00-0.869-0.1990.012

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-10SCHEDULE 13G/ASEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-15144Filing for proposed sale of securities under Rule 144.SEC
2026-07-07S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-018-KCurrent report2026-06-30SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-268-KCurrent report2026-05-19SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-18144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800113.61K1
2026-0700470.00K1
2026-060000
2026-0500350.73K2
2026-040000
2026-0300256.88K1
2026-0200155.25K1
2026-0100304.69K1
2025-12001.27M3
2025-1100121.21K1

Institutional holders

Manager% owned
BlackRock, Inc.16.58%
VANGUARD PORTFOLIO MANAGEMENT LLC6.93%
WELLINGTON MANAGEMENT GROUP LLP5.94%
DIMENSIONAL FUND ADVISORS LP5.61%
STATE STREET CORP4.59%
VANGUARD CAPITAL MANAGEMENT LLC4.33%
MILLENNIUM MANAGEMENT LLC3.81%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.3.53%
Nuveen, LLC2.86%
GEODE CAPITAL MANAGEMENT, LLC2.47%

Funds

Fund% owned
Miller Convertible Bond Fund8.80%
Miller Market Neutral Income Fund8.80%
iShares Core S&P Small-Cap ETF6.03%
Miller Intermediate Bond Fund3.30%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
Fidelity Convertible Securities Fund2.89%
iShares Russell 2000 ETF2.62%
Nomura Small Cap Core Fund2.55%
VANGUARD SMALL-CAP INDEX FUND2.18%
Small Cap Growth Fund1.44%

OakChart. OMCL. Cached 15 minutes.